Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
5,434,244
-
Total 13F shares
-
10,317,198
-
Share change
-
-6,516,012
-
Total reported value
-
$50,763,750
-
Price per share
-
$4.92
-
Number of holders
-
63
-
Value change
-
-$96,371,442
-
Number of buys
-
39
-
Number of sells
-
29
Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) as of Q4 2020
As of 31 Dec 2020,
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,317,198 shares.
The largest 10 holders included
Versant Venture Management, LLC, 5AM Venture Management, LLC, Redmile Group, LLC, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Artisan Partners Limited Partnership, MORGAN STANLEY, Candriam Luxembourg S.C.A., and CAAS CAPITAL MANAGEMENT LP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.